USE CASE:

Insurtech companies and the cost of funding signals

Here is how funding signals for insurtech companies actually gets done, what it costs each way, and where each way stops working. The tools we name are Mamba Labs Apify actors, priced per row, and Funding Press Signal Scanner is the one pointed at insurtech companies.

What is actually going wrong

Insurtech companies and funding signals: the shortcuts stop working, for one specific reason. Any funding signals method has to survive this: insurtech companies are brokers, carriers or software pretending to be one of the two, and the label rarely says which. Know this about insurtech companies before any funding signals: a broker and a carrier look identical from the homepage and buy nothing alike. Funding Press Signal Scanner carries 1 ready made setup for funding signals on insurtech companies.

Traditional Search Tools

  • The regulator's firm register, for insurtech companies. Free, and it separates the broker from the carrier in one lookup.
  • Crunchbase. The obvious answer, good coverage, and a paid tier for anything programmatic. Everyone targeting funded companies is looking at the same rows.
  • SEC EDGAR Form D. Free, authoritative, and earlier than the press by weeks in some cases. US only, and the filings are unpleasant to parse.
  • An investor's portfolio page. If you sell to one kind of company, three funds cover most of your market and both publish every new investment.
  • Read the announcements. TechCrunch, the SEC Form D feed, the company's own blog. Free, public, and about twenty minutes a day to keep up with one sector.

Mamba Labs Apify Actors

These are the actors we built for this job. If yours is not covered here, search from the bar at the top of the page or contact us here and tell us what you need.

Preconfigured tasks

A task is one of these actors with the inputs already filled in for a specific version of this job. Open one, swap in your own list, and run it without setting anything up from scratch.